With awareness of macular degeneration increasing and new diagnostic technologies resulting in earlier detection of the disease, many governments are faced with making decisions regarding coverage for … [Read more...]
Lucentis Coverage in Ontario and Quebec, Canada
The macular degeneration drug Lucentis has coverage for funding in Ontario and Quebec, Canada. Shortly after the July 30, 2007 Notice of Compliance issued by Health Canada to Novartis Ophthalmics, … [Read more...]
Lucentis Treatment – Ontario, Canada
Lucentis treatments are available for people with wet macular degeneration in Ontario, Canada. Effective March 25, 2008 the Ontario Government announced that it would provide funding for Lucentis … [Read more...]
Canada’s Drug Review Board Recommends Lucentis
Lucentis, an anti-VEGF drug for treating wet macular degeneration has been recommended by Canada's drug review board the Common Drug Review Committee (CDR). This board recommends funding of the … [Read more...]



Recent Comments